HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lijuan Qiu Selected Research

CD100 antigen

1/2022Soluble Sema4D Level Is Positively Correlated with Sema4D Expression in PBMCs and Peripheral Blast Number in Acute Leukemia.
1/2021Semaphorin 4D is a potential biomarker in pediatric leukemia and promotes leukemogenesis by activating PI3K/AKT and ERK signaling pathways.
1/2019Regulatory sequence analysis of semaphorin 4D 5' non-coding region.
1/2016The role of semaphorin 4D as a potential biomarker for antiangiogenic therapy in colorectal cancer.
1/2016The role of semaphorin 4D in tumor development and angiogenesis in human breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lijuan Qiu Research Topics

Disease

7Infections
01/2022 - 01/2014
6Neoplasms (Cancer)
01/2022 - 12/2012
3Breast Neoplasms (Breast Cancer)
01/2022 - 01/2016
2Leukemia
01/2022 - 01/2021
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2022 - 01/2021
1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
01/2022
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2022
1Cross Infection (Nosocomial Infection)
01/2022
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2022
1Communicable Diseases (Infectious Diseases)
12/2021
1Mucocutaneous Lymph Node Syndrome (Kawasaki Disease)
01/2021
1Vasculitis (Vasculitides)
01/2021
1Coinfection
03/2020
1Mycoses (Diseases, Fungus)
01/2020
1Hypoxia (Hypoxemia)
01/2019
1Carcinogenesis
01/2018
1Mycoplasma Pneumonia
01/2018
1Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2017
1Colorectal Neoplasms (Colorectal Cancer)
01/2016
1Disease Resistance
08/2015
1Chromosome Aberrations (Chromosome Abnormalities)
02/2013

Drug/Important Bio-Agent (IBA)

5CD100 antigenIBA
01/2022 - 01/2016
4Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2016
2VaccinesIBA
01/2022 - 01/2018
2Proteins (Proteins, Gene)FDA Link
01/2021 - 08/2015
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2019 - 01/2016
2Biological ProductsIBA
01/2018 - 01/2016
2MicroRNAs (MicroRNA)IBA
01/2016 - 01/2014
2Small Interfering RNA (siRNA)IBA
01/2016 - 01/2016
1HLA-DR13 antigenIBA
01/2022
1HLA-DR1 Antigen (HLA DR1 Antigen)IBA
01/2022
1Indicators and Reagents (Reagents)IBA
01/2022
1HLA-DR16 antigenIBA
01/2022
1AntibodiesIBA
01/2022
1Cytokine Receptors (Cytokine Receptor)IBA
12/2021
1CytokinesIBA
12/2021
1AntigensIBA
08/2021
1CarbohydratesIBA
08/2021
1InflammasomesIBA
01/2021
1NLR ProteinsIBA
01/2021
1Long Noncoding RNAIBA
01/2021
1jasmonic acid (jasmonate)IBA
01/2021
1Viral VaccinesIBA
03/2020
1ElementsIBA
01/2020
1Initiator Codon (Start Codon)IBA
01/2019
1LuciferasesIBA
01/2019
1NucleotidesIBA
01/2019
1DNA (Deoxyribonucleic Acid)IBA
01/2018
1Transcription Factors (Transcription Factor)IBA
01/2017
1Neutralizing AntibodiesIBA
02/2016
1Semaphorins (Semaphorin)IBA
01/2016
1Protein Kinases (Protein Kinase)IBA
08/2015
1CytochromesIBA
08/2015
1Leucine (L-Leucine)FDA Link
08/2015
1RNA (Ribonucleic Acid)IBA
01/2014
1Pharmaceutical PreparationsIBA
02/2013

Therapy/Procedure

2Therapeutics
01/2016 - 12/2012